Loading company…
uMed builds consented patient cohorts and collects data to support medical research.
Founded in 2017 and based in London, UK, uMed provides researchers with consented patient cohorts and data through its ACCESS Research Platform. The platform collects electronic health records, clinical outcomes, patient-generated data, and biosamples. In July 2023, uMed raised GBP 9.8 million in Series A funding from 11.2 Capital, AlbionVC, Delin Ventures, and Playfair Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in